{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:20:09Z","timestamp":1790886009223,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":532,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"U.S. Department of Energy, Basic Energy Sciences, Office of Science"},{"name":"National Institutes of Health, National Center for Research Resources"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.virol.2011.10.007","type":"journal-article","created":{"date-parts":[[2011,12,11]],"date-time":"2011-12-11T11:27:14Z","timestamp":1323602834000},"page":"6-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Identification of the heparin binding site on adeno-associated virus serotype 3B (AAV-3B)"],"prefix":"10.1016","volume":"423","author":[{"given":"Thomas F.","family":"Lerch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt 11","key":"10.1016\/j.virol.2011.10.007_bb0005","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1107\/S0907444902016657","article-title":"PHENIX: building new software for automated crystallographic structure determination","volume":"58","author":"Adams","year":"2002","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.virol.2011.10.007_bb0010","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1073\/pnas.83.15.5489","article-title":"Effect of errors, redundancy, and solvent content in the molecular replacement procedure for the structure determination of biological macromolecules","volume":"83","author":"Arnold","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.virol.2011.10.007_bb0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nbt.1599","article-title":"Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle","volume":"28","author":"Asokan","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virol.2011.10.007_bb0020","doi-asserted-by":"crossref","unstructured":"Ayuso, E., Mingozzi, F., Montane, J., Leon, X., Anguela, X.M., Haurigot, V., Edmonson, S.A., Africa, L., Zhou, S., High, K.A., Bosch, F., Wright, J.F., 2010. High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency. Gene Ther. 17(4), 503\u2013510.","DOI":"10.1038\/gt.2009.157"},{"key":"10.1016\/j.virol.2011.10.007_bb0025","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1073\/pnas.85.10.3304","article-title":"Structural analysis of a series of antiviral agents complexed with human rhinovirus 14","volume":"85","author":"Badger","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"14","key":"10.1016\/j.virol.2011.10.007_bb0035","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/sj.gt.3301976","article-title":"Receptor targeting of adeno-associated virus vectors","volume":"10","author":"Buning","year":"2003","journal-title":"Gene Ther."},{"issue":"3","key":"10.1016\/j.virol.2011.10.007_bb0030","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000079988","article-title":"Progress in the use of adeno-associated viral vectors for gene therapy","volume":"177","author":"Buning","year":"2004","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.virol.2011.10.007_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/SQB.1962.027.001.005","article-title":"Physical principles in the construction of regular viruses","volume":"27","author":"Caspar","year":"1962","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.virol.2011.10.007_bb0045","series-title":"Heparin-Binding Proteins","author":"Conrad","year":"1998"},{"issue":"10","key":"10.1016\/j.virol.2011.10.007_bb0220","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.gt.3302233","article-title":"Gene therapy progress and prospects: recombinant adeno-associated virus (rAAV) vectors","volume":"11","author":"Flotte","year":"2004","journal-title":"Gene Therapy"},{"issue":"3","key":"10.1016\/j.virol.2011.10.007_bb0225","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ymgme.2009.05.010","article-title":"AAV3-mediated transfer and expression of the pyruvate dehydrogenase E1 alpha subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells","volume":"98","author":"Glushakova","year":"2009","journal-title":"Mol. Genet. Metab."},{"issue":"23","key":"10.1016\/j.virol.2011.10.007_bb0060","doi-asserted-by":"crossref","first-page":"11556","DOI":"10.1128\/JVI.01536-06","article-title":"Structurally mapping the diverse phenotype of adeno-associated virus serotype 4","volume":"80","author":"Govindasamy","year":"2006","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.virol.2011.10.007_bb0065","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/sj.gt.3300946","article-title":"Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2","volume":"6","author":"Grimm","year":"1999","journal-title":"Gene Ther."},{"issue":"12","key":"10.1016\/j.virol.2011.10.007_bb0070","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1128\/JVI.00254-08","article-title":"In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses","volume":"82","author":"Grimm","year":"2008","journal-title":"J. Virol."},{"issue":"Pt 8","key":"10.1016\/j.virol.2011.10.007_bb0075","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1099\/0022-1317-81-8-2077","article-title":"Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors","volume":"81","author":"Handa","year":"2000","journal-title":"J. Gen. Virol."},{"issue":"4","key":"10.1016\/j.virol.2011.10.007_bb0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/sj.ejhg.5201153","article-title":"Advances in AAV-mediated gene transfer for the treatment of inherited disorders","volume":"12","author":"Hildinger","year":"2004","journal-title":"Eur. J. Hum. Genet."},{"issue":"41","key":"10.1016\/j.virol.2011.10.007_bb0085","doi-asserted-by":"crossref","first-page":"39969","DOI":"10.1074\/jbc.M211284200","article-title":"Crystal structures of the heparan sulfate-binding domain of follistatin. Insights into ligand binding","volume":"278","author":"Innis","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.virol.2011.10.007_bb0090","doi-asserted-by":"crossref","first-page":"11072","DOI":"10.1128\/JVI.77.20.11072-11081.2003","article-title":"Identification of a heparin-binding motif on adeno-associated virus type 2 capsids","volume":"77","author":"Kern","year":"2003","journal-title":"J. Virol."},{"issue":"Pt 12 Pt 1","key":"10.1016\/j.virol.2011.10.007_bb0095","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1107\/S0907444904013253","article-title":"The Uppsala Electron-Density Server","volume":"60","author":"Kleywegt","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"Pt 2","key":"10.1016\/j.virol.2011.10.007_bb0105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1107\/S1744309109000372","article-title":"Twinned crystals of adeno-associated virus serotype 3b prove suitable for structural studies","volume":"65","author":"Lerch","year":"2009","journal-title":"Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun."},{"issue":"1","key":"10.1016\/j.virol.2011.10.007_bb0100","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.virol.2010.03.027","article-title":"The structure of adeno-associated virus serotype 3B (AAV-3B): insights into receptor binding and immune evasion","volume":"403","author":"Lerch","year":"2010","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.virol.2011.10.007_bb0110","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jsb.2008.12.002","article-title":"Heparin binding induces conformational changes in adeno-associated virus serotype 2","volume":"165","author":"Levy","year":"2009","journal-title":"J. Struct. Biol."},{"issue":"5","key":"10.1016\/j.virol.2011.10.007_bb0115","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/156652310793180706","article-title":"AAV's anatomy: roadmap for optimizing vectors for translational success","volume":"10","author":"Mitchell","year":"2010","journal-title":"Curr. Gene Ther."},{"issue":"22","key":"10.1016\/j.virol.2011.10.007_bb0120","doi-asserted-by":"crossref","first-page":"12260","DOI":"10.1128\/JVI.01304-07","article-title":"Structure of adeno-associated virus serotype 8, a gene therapy vector","volume":"81","author":"Nam","year":"2007","journal-title":"J. Virol."},{"issue":"24","key":"10.1016\/j.virol.2011.10.007_bb0125","doi-asserted-by":"crossref","first-page":"12945","DOI":"10.1128\/JVI.01235-10","article-title":"Structural characterization of the dual glycan binding adeno-associated virus serotype 6","volume":"84","author":"Ng","year":"2010","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2011.10.007_bb0130","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.virol.2008.11.037","article-title":"Adeno-associated virus-2 and its primary cellular receptor\u2014cryo-EM structure of a heparin complex","volume":"385","author":"O'Donnell","year":"2009","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.virol.2011.10.007_bb0135","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1128\/JVI.77.12.6995-7006.2003","article-title":"Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding","volume":"77","author":"Opie","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.10.007_bb0140","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"issue":"14","key":"10.1016\/j.virol.2011.10.007_bb0145","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1128\/JVI.00076-06","article-title":"Heparan sulfate proteoglycan binding properties of adeno-associated virus retargeting mutants and consequences for their in vivo tropism","volume":"80","author":"Perabo","year":"2006","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2011.10.007_bb0150","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JVI.76.2.791-801.2002","article-title":"Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity","volume":"76","author":"Rabinowitz","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2011.10.007_bb0155","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1107\/S0108767386099622","article-title":"Improved Fourier coefficients for maps using phases from partial structures with errors","volume":"42","author":"Read","year":"1986","journal-title":"Acta Crystallogr. A"},{"key":"10.1016\/j.virol.2011.10.007_bb0160","doi-asserted-by":"crossref","first-page":"14587","DOI":"10.1016\/S0021-9258(18)63732-9","article-title":"The Canyon hypothesis","volume":"264","author":"Rossmann","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.virol.2011.10.007_bb0165","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/JVI.72.1.309-319.1998","article-title":"Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2","volume":"72","author":"Rutledge","year":"1998","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virol.2011.10.007_bb0170","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S1525-0016(03)00042-X","article-title":"RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism","volume":"7","author":"Shi","year":"2003","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.virol.2011.10.007_bb0175","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/hum.2006.17.353","article-title":"Insertional mutagenesis at positions 520 and 584 of adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors with eliminated heparin-binding ability and introduced novel tropism","volume":"17","author":"Shi","year":"2006","journal-title":"Hum. Gene Ther."},{"issue":"13","key":"10.1016\/j.virol.2011.10.007_bb0180","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1021\/bi00179a006","article-title":"Energetic characterization of the basic fibroblast growth factor\u2013heparin interaction: identification of the heparin binding domain","volume":"33","author":"Thompson","year":"1994","journal-title":"Biochemistry"},{"issue":"16","key":"10.1016\/j.virol.2011.10.007_bb0185","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1089\/10430340260355347","article-title":"Insect cells as a factory to produce adeno-associated virus type 2 vectors","volume":"13","author":"Urabe","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.virol.2011.10.007_bb0190","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-1-59745-210-6_2","article-title":"The role of the adeno-associated virus capsid in gene transfer","volume":"437","author":"Van Vliet","year":"2008","journal-title":"Methods Mol. Biol."},{"issue":"19","key":"10.1016\/j.virol.2011.10.007_bb0195","doi-asserted-by":"crossref","first-page":"9281","DOI":"10.1128\/JVI.74.19.9281-9293.2000","article-title":"Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection","volume":"74","author":"Wobus","year":"2000","journal-title":"J. Virol."},{"issue":"16","key":"10.1016\/j.virol.2011.10.007_bb0200","doi-asserted-by":"crossref","first-page":"10405","DOI":"10.1073\/pnas.162250899","article-title":"The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy","volume":"99","author":"Xie","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.virol.2011.10.007_bb0205","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jviromet.2004.07.007","article-title":"Large-scale production, purification and crystallization of wild-type adeno-associated virus-2","volume":"122","author":"Xie","year":"2004","journal-title":"J. Virol. Methods"},{"issue":"3","key":"10.1016\/j.virol.2011.10.007_bb0210","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/1566523054065039","article-title":"Immune responses to adeno-associated virus vectors","volume":"5","author":"Zaiss","year":"2005","journal-title":"Curr. Gene Ther."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682211004764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682211004764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:14:06Z","timestamp":1758586446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682211004764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0042682211004764"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2011.10.007","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of the heparin binding site on adeno-associated virus serotype 3B (AAV-3B)","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2011.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}